100 related articles for article (PubMed ID: 20594067)
41. Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas.
Geli J; Nord B; Frisk T; Edström Elder E; Ekström TJ; Carling T; Bäckdahl M; Larsson C
Int J Oncol; 2005 May; 26(5):1385-91. PubMed ID: 15809732
[TBL] [Abstract][Full Text] [Related]
42. Gene transfections with p53 and p21 inhibit cell proliferation, collagen type I, leukemia inhibitory factor, and tumor necrosis factor-alpha expression in leiomyoma cells.
Hsieh YY; Chang CC; Hsu CW; Lin CS
Fertil Steril; 2004 Jun; 81(6):1665-70. PubMed ID: 15193492
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled through the 75-kilodalton tumor necrosis factor receptor. Regulation of c-kit and p53 expression.
Jacobsen FW; Dubois CM; Rusten LS; Veiby OP; Jacobsen SE
J Immunol; 1995 Apr; 154(8):3732-41. PubMed ID: 7535812
[TBL] [Abstract][Full Text] [Related]
44. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
45. Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signaling.
Ros JE; Schuetz JD; Geuken M; Streetz K; Moshage H; Kuipers F; Manns MP; Jansen PL; Trautwein C; Müller M
Hepatology; 2001 Jun; 33(6):1425-31. PubMed ID: 11391531
[TBL] [Abstract][Full Text] [Related]
46. Peptide YY reverses TNF-alpha induced transcription factor binding of interferon regulatory factor-1 and p53 in pancreatic acinar cells.
Rizvi IA; Robinson K; McFadden DW; Riggs DR; Jackson BJ; Vona-Davis L
J Surg Res; 2006 Nov; 136(1):25-30. PubMed ID: 16978650
[TBL] [Abstract][Full Text] [Related]
47. Fc epsilonRI-mediated induction of TNF-alpha gene expression in the RBL-2H3 mast cell line: regulation by a novel NF-kappaB-like nuclear binding complex.
Pelletier C; Varin-Blank N; Rivera J; Iannascoli B; Marchand F; David B; Weyer A; Blank U
J Immunol; 1998 Nov; 161(9):4768-76. PubMed ID: 9794408
[TBL] [Abstract][Full Text] [Related]
48. topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.
Lin L; Ozaki T; Takada Y; Kageyama H; Nakamura Y; Hata A; Zhang JH; Simonds WF; Nakagawara A; Koseki H
Oncogene; 2005 May; 24(21):3385-96. PubMed ID: 15735665
[TBL] [Abstract][Full Text] [Related]
49. RIZ1 and histone methylation status in pituitary adenomas.
Xue Y; Chen R; Du W; Yang F; Wei X
Tumour Biol; 2017 Jul; 39(7):1010428317711794. PubMed ID: 28718376
[TBL] [Abstract][Full Text] [Related]
50. The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter.
Liu L; Shao G; Steele-Perkins G; Huang S
J Biol Chem; 1997 Jan; 272(5):2984-91. PubMed ID: 9006946
[TBL] [Abstract][Full Text] [Related]
51. The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomas.
Ding MH; Wang Z; Jiang L; Fu HL; Gao J; Lin XB; Zhang CL; Liu ZY; Shi YF; Qiu GZ; Ma Y; Cui DX; Hu GH; Jin WL
Biomaterials; 2015 Jul; 56():165-78. PubMed ID: 25934289
[TBL] [Abstract][Full Text] [Related]
52. Repression of Akt3 gene transcription by the tumor suppressor RIZ1.
Liu Q; Qu X; Xie X; He P; Huang S
Sci Rep; 2018 Jan; 8(1):1528. PubMed ID: 29367689
[TBL] [Abstract][Full Text] [Related]
53. Suppression of RIZ in biologically unfavourable neuroblastomas.
Geli J; Kiss N; Kogner P; Larsson C
Int J Oncol; 2010 Nov; 37(5):1323-30. PubMed ID: 20878080
[TBL] [Abstract][Full Text] [Related]
54. Synergism between RIZ1 gene therapy and paclitaxel in SiHa cervical cancer cells.
Cheng HY; Zhang T; Qu Y; Shi WJ; Lou G; Liu YX; Zhang YY; Cheng L
Cancer Gene Ther; 2016 Nov; 23(11):392-395. PubMed ID: 27713401
[TBL] [Abstract][Full Text] [Related]
55. Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1.
Jiang Gl; Liu L; Buyse IM; Simon D; Huang S
Int J Cancer; 1999 Nov; 83(4):541-6. PubMed ID: 10508492
[TBL] [Abstract][Full Text] [Related]
56. [Methylation status of RIZ1 gene promoter in myelodysplastic syndrome].
Xu RR; Xuan LN; Wang Y
Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):774-5. PubMed ID: 23336240
[No Abstract] [Full Text] [Related]
57. RIZ1 is regulated by estrogen and suppresses tumor progression in endometrial cancer.
Yang T; Ren C; Jiang A; Yu Z; Li G; Wang G; Zhang Q
Biochem Biophys Res Commun; 2017 Jul; 489(2):96-102. PubMed ID: 28528974
[TBL] [Abstract][Full Text] [Related]
58. Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma.
Abbondanza C; de Nigris F; De Rosa C; Rossiello R; Puca GA; Napoli C
Oncol Res; 2008; 17(1):33-41. PubMed ID: 18488713
[TBL] [Abstract][Full Text] [Related]
59. Tumor suppressor RIZ1 in obesity and the PI3K/AKT/mTOR pathway.
Xie X; Man X; Zhu Z; Yuan D; Huang S
Obesity (Silver Spring); 2016 Feb; 24(2):389-97. PubMed ID: 26709097
[TBL] [Abstract][Full Text] [Related]
60. The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression.
Huang S; Shao G; Liu L
J Biol Chem; 1998 Jun; 273(26):15933-9. PubMed ID: 9632640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
